Elizabeth A. Yamashita - Net Worth and Insider Trading

Elizabeth A. Yamashita Net Worth

The estimated net worth of Elizabeth A. Yamashita is at least $2,553 dollars as of 2024-11-10. Elizabeth A. Yamashita is the VP, Regulatory Affairs of Outlook Therapeutics Inc and owns about 404 shares of Outlook Therapeutics Inc (OTLK) stock worth over $2,553. Details can be seen in Elizabeth A. Yamashita's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elizabeth A. Yamashita has not made any transactions after 2017-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Elizabeth A. Yamashita

To

Elizabeth A. Yamashita Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elizabeth A. Yamashita owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .

Click here to see the complete history of Elizabeth A. Yamashita’s form 4 insider trades.

Insider Ownership Summary of Elizabeth A. Yamashita

Ticker Comapny Transaction Date Type of Owner
OTLK Outlook Therapeutics Inc 2017-12-22 VP & Regulatory Affairs

Elizabeth A. Yamashita Latest Holdings Summary

Elizabeth A. Yamashita currently owns a total of 1 stock. Elizabeth A. Yamashita owns 404 shares of Outlook Therapeutics Inc (OTLK) as of December 22, 2017, with a value of $2,553.

Latest Holdings of Elizabeth A. Yamashita

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OTLK Outlook Therapeutics Inc 2017-12-22 404 6.32 2,553

Holding Weightings of Elizabeth A. Yamashita


Elizabeth A. Yamashita Form 4 Trading Tracker

According to the SEC Form 4 filings, Elizabeth A. Yamashita has made a total of 0 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years. The most-recent trade in Outlook Therapeutics Inc is the sale of 101 shares on December 22, 2017, which brought Elizabeth A. Yamashita around $18,272.

Insider Trading History of Elizabeth A. Yamashita

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Elizabeth A. Yamashita Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elizabeth A. Yamashita Ownership Network

Ownership Network List of Elizabeth A. Yamashita

No Data

Ownership Network Relation of Elizabeth A. Yamashita

Insider Network Chart

Elizabeth A. Yamashita Owned Company Details

What does Outlook Therapeutics Inc do?

Who are the key executives at Outlook Therapeutics Inc?

Elizabeth A. Yamashita is the VP & Regulatory Affairs of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and Chief Operating Officer Terry Dagnon .

Outlook Therapeutics Inc (OTLK) Insider Trades Summary

Over the past 18 months, Elizabeth A. Yamashita made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .

In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.

Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Outlook Therapeutics Inc Insider Transactions

No Available Data

Elizabeth A. Yamashita Mailing Address

Above is the net worth, insider trading, and ownership report for Elizabeth A. Yamashita. You might contact Elizabeth A. Yamashita via mailing address: C/o Oncobiologics, Inc., 7 Clarke Drive, Cranbury Nj 08512.